🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Inotiv settles with DOJ over animal welfare, environmental issues

EditorBrando Bricchi
Published 03/06/2024, 18:38
NOTV
-

WEST LAFAYETTE, Ind. - Inotiv Inc. (NASDAQ:NOTV), a prominent contract research organization, has reached a settlement with the U.S. Department of Justice (DOJ) to conclude a criminal investigation into alleged violations at a canine breeding facility in Cumberland, Virginia. The facility, formerly operated by Envigo RMS LLC, a company Inotiv acquired in November 2021, faced scrutiny over compliance with the Animal Welfare Act and the Clean Water Act.

In a plea agreement, Envigo RMS LLC admitted to one misdemeanor count of conspiracy to violate the Animal Welfare Act, while Envigo Global Services, Inc. pleaded guilty to a felony count of conspiracy under the Clean Water Act. Inotiv, in a statement released today, expressed its commitment to resolving the uncertainties surrounding the investigation and to refocusing on its mission to advance drug discovery and development.

As part of the settlement, Inotiv has agreed to pay $22 million in fines over four years, starting in June 2025. Additionally, the company will invest at least $7 million over the next three years to enhance animal welfare at its facilities. Inotiv has also disbursed $3 million to the Virginia Animal Fighting Taskforce and the Humane Society of the United States as recognition of their assistance in the government's investigation. Furthermore, $3.5 million has been allocated to the National Fish and Wildlife Foundation to support environmental initiatives near the Cumberland site.

The resolution includes non-monetary conditions and an amendment to Inotiv's credit facilities to ensure compliance with the settlement terms. Looking ahead, Inotiv plans to implement leading animal welfare practices and foster a culture of compliance across its operations.

Inotiv's services are integral to the early stages of drug and medical device development, aiming to enhance efficiency, data quality, and cost-effectiveness in bringing new treatments to market. The company has stated its dedication to upholding high standards of animal welfare and regulatory compliance.

This news is based on a press release statement from Inotiv Inc. and is currently pending court approval at a sentencing hearing. Further details about Inotiv's commitment to animal welfare can be found on the company's website.

InvestingPro Insights

In the wake of reaching a settlement with the DOJ, Inotiv Inc. (NASDAQ:NOTV) faces the challenge of navigating a period of financial and operational adjustment. The InvestingPro data highlights several critical metrics that investors should consider. With a market capitalization of $50.12 million, the company's financial size remains modest in the expansive field of contract research organizations. The revenue for the last twelve months as of Q2 2024 stands at $552.74 million, indicating a notable presence in the industry despite a -7.47% decline in revenue growth during the same period.

Investors might also note the significant price volatility of Inotiv's stock, with a 1-month total return plummeting by -56.21% and a 3-month total return of -76.6%. This reflects the recent challenges the company has faced and may be of particular interest to those considering the timing of their investments. Additionally, the company's stock is currently trading at 16.86% of its 52-week high, which could suggest a potential discount for value-seeking investors, especially in light of the recent settlement.

Turning to InvestingPro Tips, two insights stand out. Firstly, the RSI suggests the stock is in oversold territory, which could indicate a potential rebound or at least a stabilization in the near term. Secondly, the valuation implies a strong free cash flow yield, which could attract investors looking for companies with the ability to generate cash after accounting for capital expenditures. These insights, combined with the 12 additional tips available on InvestingPro, could provide a more nuanced understanding of Inotiv's investment potential.

For readers interested in a deeper dive into Inotiv's financial health and market prospects, InvestingPro offers a comprehensive suite of tools and analytics. By using the coupon code PRONEWS24, readers can get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking further insights that could guide investment decisions during this pivotal time for the company. Visit https://www.investing.com/pro/NOTV to explore the full range of InvestingPro Tips and metrics.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.